INS and type 2 diabetes mellitus: With these objectives in mind, we successfully developed a male rodent model of late-stage T2D characterized by significantly higher HbA1c, insulin resistance and defective glucagon counterregulation to insulin-induced hypoglycemia compared to HFF and NCF controls.